Clinical Trial Update: Chemosensitization With Plerixafor Plus G-CSF in Acute Myeloid Leukemia [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluating chemosensitization with plerixafor plus G-CSF in acute myeloid leukemia has completed, with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Filgrastim (filgrastim)
• Mozobil (plerixafor)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Leukemia, Myeloid, Acute | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2017-04-04